Freitas, P., Ferreira, A., Arteaga-Fernández, E., de Oliveira Antunes, M., Mesquita, J., Abecasis, J., . . . Rochitte, C. (2019). The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.
Referência de acordo com a norma ChicagoFreitas, P., et al. The Amount of Late Gadolinium Enhancement Outperforms Current Guideline-recommended Criteria in the Identification of Patients With Hypertrophic Cardiomyopathy At Risk of Sudden Cardiac Death. 2019.
Referência de acordo com a norma MLAFreitas, P., et al. The Amount of Late Gadolinium Enhancement Outperforms Current Guideline-recommended Criteria in the Identification of Patients With Hypertrophic Cardiomyopathy At Risk of Sudden Cardiac Death. 2019.